> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hospira Recalls 1 Lot of Bacteriostatic Water
- URL: https://www.fdaweb.com/hospira-recalls-1-lot-of-bacteriostatic-water/
- Published: 2019-09-11T12:00:00.000Z
- Updated: 2026-09-15T01:49:12.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144981

Hospira has recalled one lot (# W20308) of its bacteriostatic water for injection, USP, 30 mL, multi-dose vial due to sterilization concerns. “In the event that impacted product is administered to a patient, there is an increased risk that severe adverse events such as invasive bacterial infection, including bacterial meningitis, septicemia, and limited adverse events such as fever, chills, malaise, and cutaneous abscess may occur,” a [recall notice](http://s2027422842.t.en25.com/e/es?s=2027422842&e=251743&elqTrackId=376c7bc788024cd5a73d955f2e3dcbdc&elq=669b6ef7c3c34878a9a8367d05ec5bbe&elqaid=9407&elqat=1&ref=fdaweb.com) says. To date, Hospira says it has not received any adverse event reports associated with this issue. Bacteriostatic water is a sterile, nonpyrogenic preparation of water for injection containing 0.9% of benzyl alcohol added as a bacteriostatic preservative. It is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection.